3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
40
Myelodysplastic Syndromes
8
Leukemia, Biphenotypic, Acute
6
Leukemia
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Neoplasm, Residual
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid
2
Blast Crisis
2
Sarcoma, Myeloid
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Hematologic Neoplasms
1
Down Syndrome
1
Congenital Abnormalities
1
Carcinoma, Hepatocellular
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
8
Methotrexate
6
ponatinib
5
fludarabine phosphate
5
merphos
4
Whole-Body Irradiation
4
Tacrolimus
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cytarabine
3
CT-P10
3
Busulfan
3
letermovir
2
blinatumomab
2
Vincristine
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Melphalan
2
Cyclosporine
2
venetoclax
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
bosutinib
1
auricularum
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
Idarubicin
×
1 year
×
Clear all
No trials found.